{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:57:04Z","timestamp":1791687424390,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":528,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1038\/s41379-021-00796-9","type":"journal-article","created":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T08:02:35Z","timestamp":1617696155000},"page":"1495-1506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Morphologic subtypes of lobular carcinoma in situ diagnosed on core needle biopsy: clinicopathologic features and findings at follow-up excision"],"prefix":"10.1016","volume":"34","author":[{"given":"M. Gabriela","family":"Kuba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2935-6014","authenticated-orcid":false,"given":"Melissa P.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Coffey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina","family":"Calle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4737-8468","authenticated-orcid":false,"given":"Edi","family":"Brogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-021-00796-9_bib1","unstructured":"Chen YY, Decker T, King TA, Palacios J, Shin SJ, Simpson PT lobular carcinoma in situ. In: WHO classification of tumours editorial board. breast tumours. 5th ed. Lyon, France: IARC; 2019. p. 71\u20134"},{"key":"10.1038\/s41379-021-00796-9_bib2","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/01.pai.0000213128.78665.3c","article-title":"The spectrum of morphomolecular abnormalities of the E-cadherin\/catenin complex in pleomorphic lobular carcinoma of the breast","volume":"15","author":"Dabbs","year":"2007","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1038\/s41379-021-00796-9_bib3","first-page":"491","article-title":"Lobular carcinoma in situ: a rare form of mammary cancer","volume":"17","author":"Foote","year":"1941","journal-title":"Am J Pathol"},{"key":"10.1038\/s41379-021-00796-9_bib4","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/0046-8177(91)90105-X","article-title":"Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease","volume":"22","author":"Page","year":"1991","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-021-00796-9_bib5","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1200\/JCO.2015.61.4743","article-title":"Lobular carcinoma in situ: a 29-Year longitudinal experience evaluating clinicopathologic features and breast cancer risk","volume":"33","author":"King","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-021-00796-9_bib6","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ejso.2010.05.019","article-title":"Risk of invasive breast cancer after lobular intra-epithelial neoplasia: review of the literature","volume":"36","author":"Ansquer","year":"2010","journal-title":"Eur J Surg Oncol"},{"key":"10.1038\/s41379-021-00796-9_bib7","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/cncr.27841","article-title":"Classic lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous breast core biopsy: outcomes of prospective excision","volume":"119","author":"Murray","year":"2013","journal-title":"Cancer"},{"key":"10.1038\/s41379-021-00796-9_bib8","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1245\/s10434-015-4922-4","article-title":"Incidence of adjacent synchronous invasive carcinoma and\/or ductal carcinoma in-situ in patients with lobular neoplasia on core biopsy: results from a prospective multi-institutional registry (TBCRC 020)","volume":"23","author":"Nakhlis","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1038\/s41379-021-00796-9_bib9","doi-asserted-by":"crossref","first-page":"929","DOI":"10.2214\/AJR.11.8447","article-title":"Is excisional biopsy required after a breast core biopsy yields lobular neoplasia?","volume":"199","author":"Niell","year":"2012","journal-title":"AJR Am J Roentgenol"},{"key":"10.1038\/s41379-021-00796-9_bib10","doi-asserted-by":"crossref","first-page":"927","DOI":"10.5858\/arpa.2012-0297-OA","article-title":"Pathologic upgrade rates on subsequent excision when lobular carcinoma in situ is the primary diagnosis in the needle core biopsy with special attention to the radiographic target","volume":"137","author":"D'Alfonso","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/s41379-021-00796-9_bib11","unstructured":"Lakhani SR, Schnitt SJ, O'Malley F, van de Vijver MJ, Simpson PT, Palacios J Lobular neoplasia. In: Lakhani SR, Ellis I, Schnitt SJ, Tan PH, Van de Vijver MJ, editors. WHO Classification of Tumours of the Breast. Geneva, Switzerland: WHO Press; 2012. p. 78-80"},{"key":"10.1038\/s41379-021-00796-9_bib12","first-page":"27","article-title":"Pleomorphic lobular carcinoma in situ","volume":"1","author":"Frost","year":"1996","journal-title":"AJSP: Rev Rep"},{"key":"10.1038\/s41379-021-00796-9_bib13","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1097\/00000478-200012000-00009","article-title":"Pleomorphic lobular carcinoma: morphology, immunohistochemistry, and molecular analysis","volume":"24","author":"Middleton","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00796-9_bib14","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1097\/01.pas.0000213290.58283.82","article-title":"Lobular intraepithelial neoplasia [lobular carcinoma in situ] with comedo-type necrosis: a clinicopathologic study of 18 cases","volume":"30","author":"Fadare","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00796-9_bib15","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1097\/PAS.0b013e31817dc3a6","article-title":"Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile","volume":"32","author":"Chivukula","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00796-9_bib16","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/modpathol.2008.134","article-title":"Atypical lobular hyperplasia and classic lobular carcinoma in situ in core biopsy specimens: routine excision is not necessary","volume":"21","author":"Hwang","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00796-9_bib17","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2559.2010.03634.x","article-title":"Screen-detected pleomorphic lobular carcinoma in situ (PLCIS): risk of concurrent invasive malignancy following a core biopsy diagnosis","volume":"57","author":"Carder","year":"2010","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00796-9_bib18","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.5858\/2009-0300-OA.1","article-title":"Lobular carcinoma in situ variants in breast cores: potential for misdiagnosis, upgrade rates at surgical excision, and practical implications","volume":"134","author":"Sullivan","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/s41379-021-00796-9_bib19","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1245\/s10434-015-4552-x","article-title":"Pleomorphic lobular carcinoma in situ: radiologic-pathologic features and clinical management","volume":"22","author":"Flanagan","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1038\/s41379-021-00796-9_bib20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.clbc.2016.06.003","article-title":"Surgical outcomes of lobular neoplasia diagnosed in core biopsy: prospective study of 316 cases","volume":"16","author":"Susnik","year":"2016","journal-title":"Clin Breast Cancer"},{"key":"10.1038\/s41379-021-00796-9_bib21","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/PAS.0000000000001191","article-title":"Pleomorphic and florid lobular carcinoma in situ variants of the breast: a clinicopathologic study of 85 cases with and without invasive carcinoma from a single academic center","volume":"43","author":"Shamir","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00796-9_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1245\/s10434-018-6937-0","article-title":"Evaluating the rate of upgrade to invasive breast cancer and\/or ductal carcinoma in situ following a core biopsy diagnosis of non-classic lobular carcinoma in situ","volume":"26","author":"Nakhlis","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1038\/s41379-021-00796-9_bib23","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/tbj.12843","article-title":"Characteristics and clinical outcomes of pleomorphic lobular carcinoma in situ of the breast","volume":"24","author":"Fasola","year":"2018","journal-title":"Breast J"},{"key":"10.1038\/s41379-021-00796-9_bib24","doi-asserted-by":"crossref","first-page":"e449","DOI":"10.1016\/j.clbc.2017.10.004","article-title":"Pleomorphic lobular carcinoma in situ diagnosed by breast core biopsy: clinicopathologic features and correlation with subsequent excision","volume":"18","author":"Guo","year":"2018","journal-title":"Clin Breast Cancer"},{"key":"10.1038\/s41379-021-00796-9_bib25","doi-asserted-by":"crossref","first-page":"462","DOI":"10.2214\/AJR.17.19088","article-title":"Pleomorphic lobular carcinoma in situ: imaging features, upgrade rate, and clinical outcomes","volume":"211","author":"Savage","year":"2018","journal-title":"AJR Am J Roentgenol"},{"key":"10.1038\/s41379-021-00796-9_bib26","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.breast.2017.12.011","article-title":"Pleomorphic LCIS what do we know? A UK multicenter audit of pleomorphic lobular carcinoma in situ","volume":"38","author":"Masannat","year":"2018","journal-title":"Breast"},{"key":"10.1038\/s41379-021-00796-9_bib27","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1245\/s10434-018-6591-6","article-title":"Treatment outcomes for pleomorphic lobular carcinoma in situ of the breast","volume":"25","author":"Desai","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1038\/s41379-021-00796-9_bib28","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.suronc.2019.01.009","article-title":"Breast-conserving surgery for pure non-classic lobular carcinoma in situ: a single institution's experience","volume":"28","author":"Hoffman","year":"2019","journal-title":"Surg Oncol"},{"key":"10.1038\/s41379-021-00796-9_bib29","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/j.ejso.2019.07.011","article-title":"Pre-operative management of pleomorphic and florid lobular carcinoma in situ of the breast: Report of a large multi-institutional series and review of the literature","volume":"45","author":"Foschini","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1038\/s41379-021-00796-9_bib30","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","article-title":"American society of clinical oncology\/college of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer","volume":"28","author":"Hammond","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-021-00796-9_bib31","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.5858\/arpa.2018-0902-SA","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: American society of clinical oncology\/college of American pathologists clinical practice guideline focused update","volume":"142","author":"Wolff","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/s41379-021-00796-9_bib32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/his.12869","article-title":"E-cadherin immunohistochemistry in breast pathology: uses and pitfalls","volume":"68","author":"Canas-Marques","year":"2016","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00796-9_bib33","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/PAS.0b013e3182918a2b","article-title":"Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry","volume":"37","author":"Dabbs","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00796-9_bib34","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10549-017-4334-1","article-title":"Pleomorphic lobular carcinoma in situ of the breast: a single institution experience with clinical follow-up and centralized pathology review","volume":"165","author":"De Brot","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1038\/s41379-021-00796-9_bib35","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41379-019-0449-8","article-title":"Genetic analysis of pleomorphic and florid lobular carcinoma in situ variants: frequent ERBB2\/ERBB3 alterations and clonal relationship to classic lobular carcinoma in situ and invasive lobular carcinoma","volume":"33","author":"Shamir","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00796-9_bib36","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/s41379-020-0459-6","article-title":"Genomic profiling of pleomorphic and florid lobular carcinoma in situ reveals highly recurrent ERBB2 and ERRB3 alterations","volume":"33","author":"Harrison","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00796-9_bib37","unstructured":"Hortobagyi GN, Connolly JL, D'Orsi CJ, Edge SB, Mittendorf EA, Rugo HS, et al. Breast. In: The AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017. p. 589-636"},{"key":"10.1038\/s41379-021-00796-9_bib38","unstructured":"National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology, Breast Cancer, [Internet], Version 6.2020 [Cited 24 November 2020]. Available from https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf"},{"key":"10.1038\/s41379-021-00796-9_bib39","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1093\/annonc\/mdz189","article-title":"Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Cardoso","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1038\/s41379-021-00796-9_bib40","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/tbj.12062","article-title":"Breast surgeon's survey: no consensus for surgical treatment of pleomorphic lobular carcinoma in situ","volume":"19","author":"Blair","year":"2013","journal-title":"Breast J"},{"key":"10.1038\/s41379-021-00796-9_bib41","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/his.12353","article-title":"Pleomorphic lobular carcinoma in situ of the breast: clinicopathological review of 47 cases","volume":"64","author":"Khoury","year":"2014","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00796-9_bib42","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0046-8177(84)80053-2","article-title":"Apocrine differentiation in lobular carcinoma of the breast: a morphologic, immunologic, and ultrastructural study","volume":"15","author":"Eusebi","year":"1984","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-021-00796-9_bib43","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.humpath.2013.04.004","article-title":"Florid lobular carcinoma in situ: molecular profiling and comparison to classic lobular carcinoma in situ and pleomorphic lobular carcinoma in situ","volume":"44","author":"Shin","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-021-00796-9_bib44","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.path.2017.09.009","article-title":"Lobular Carcinoma In Situ","volume":"11","author":"Wen","year":"2018","journal-title":"Surg Pathol Clin"},{"key":"10.1038\/s41379-021-00796-9_bib45","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1097\/PAS.0b013e3181b18a89","article-title":"Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast","volume":"33","author":"Chen","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00796-9_bib46","doi-asserted-by":"crossref","first-page":"151481","DOI":"10.1016\/j.anndiagpath.2020.151481","article-title":"American registry of pathology expert opinions: the spectrum of lobular carcinoma in situ: diagnostic features and clinical implications","volume":"45","author":"Schnitt","year":"2020","journal-title":"Ann Diagn Pathol"},{"key":"10.1038\/s41379-021-00796-9_bib47","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/PAS.0b013e318212acd3","article-title":"Microinvasive (T1mic) lobular carcinoma of the breast: clinicopathologic profile of 16 cases","volume":"35","author":"Ross","year":"2011","journal-title":"Am J Surg Pathol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41379-021-00796-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-021-00796-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222005646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222005646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-021-00796-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:35:55Z","timestamp":1760229355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222005646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0893395222005646"],"URL":"https:\/\/doi.org\/10.1038\/s41379-021-00796-9","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Morphologic subtypes of lobular carcinoma in situ diagnosed on core needle biopsy: clinicopathologic features and findings at follow-up excision","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-021-00796-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}